Michael Scott Anderson
Chairman of the Board
MIT-trained bioengineer leading long-term strategy, major investment decisions and global partnerships.
View profileDr. Michael Scott Anderson serves as Chairman of the Board of Horizon Crest Capital. He holds a Ph.D. in Bioengineering from the Massachusetts Institute of Technology (MIT) and has long focused on biomedical engineering, healthcare technology innovation and interdisciplinary research collaboration. Dr. Anderson also serves as an adviser to several international medical-engineering organisations.
At Horizon Crest Capital, Dr. Anderson is responsible for the firm's long-term strategic planning, major investment decisions and global partnership development. He is committed to deepening the integration of financial capital with medical technology, artificial intelligence and the life sciences, with a focus on innovative projects that combine technical barriers, clinical value and long-term growth potential. He also contributes to the firm's risk management, portfolio optimization and governance framework, helping ensure that the pursuit of long-term returns is matched by prudent, transparent and professional operations.
